glp-1 colorectal cancer death risk study november 2025 mortality Long-term cancer in users of GLP-1 agonists in Denmark: a nationwide emulated trial Oncology Letters
Description
They slow digestion , reducing blood sugar spikes
Incretin pharmacology: a review of the incretin effect and current incretin-based therapies
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration
These mechanisms are great for weight loss, but they can also affect how your body absorbs and utilizes nutrients
Dual engine-driven bionic microneedles for early intervention and prolonged treatment of Alzheimers disease
